180 Life Sciences Corp. Profile Avatar - Palmy Investing

180 Life Sciences Corp.

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor ne…

Biotechnology
US, Palo Alto [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of ATNF's Analysis
CIK: 1690080 CUSIP: 68236V104 ISIN: US68236V3024 LEI: - UEI: -
Secondary Listings
ATNF has no secondary listings inside our databases.